Literature DB >> 24826110

7-Chloro-4-(2-hy-droxy-ethyl-amino)-quinolin-1-ium chloride.

Ivson L Gama1, Marcus V N de Souza1, James L Wardell2, Edward R T Tiekink3.   

Abstract

In the title salt, C11H12ClN2O(+)·Cl(-), the ten non-H atoms comprising the quinolinium residue are coplanar (r.m.s. deviation = 0.041 Å) and the hy-droxy-ethyl group is approximately perpendicular to this plane [Cring-N-Cmethyl-ene-C torsion angle = -74.61 (18)°]. A supra-molecular chain aligned along [101] mediated by charge-assisted O/N-H⋯Cl(-) hydrogen bonds features in the crystal packing. Chains are connected into a three-dimensional architecture by C-H⋯O(hy-droxy) inter-actions.

Entities:  

Year:  2014        PMID: 24826110      PMCID: PMC3998632          DOI: 10.1107/S1600536814004565

Source DB:  PubMed          Journal:  Acta Crystallogr Sect E Struct Rep Online        ISSN: 1600-5368


Related literature

For the wide range of pharmacological activities of synthetic and natural products containing the quinoline nucleus, see: Andrade et al. (2007 ▶); Cunico et al. (2006 ▶); Font et al. (1997 ▶); Kaminsky & Meltzer (1968 ▶); Musiol et al. (2006 ▶); Nakamura et al. (1999 ▶); Sloboda et al., (1991 ▶); de Souza et al. (2014 ▶); Tanenbaum & Tuffanelli (1980 ▶); Warshakoon et al. (2006 ▶). For the crystal structures of related 4-RN(H)-7-chloro­quinolines, see: Kaiser et al., (2009 ▶).

Experimental

Crystal data

C11H12ClN2O+·Cl− M = 259.13 Monoclinic, a = 8.2438 (13) Å b = 16.405 (2) Å c = 8.8561 (14) Å β = 110.705 (2)° V = 1120.3 (3) Å3 Z = 4 Mo Kα radiation μ = 0.56 mm−1 T = 100 K 0.20 × 0.07 × 0.04 mm

Data collection

Rigaku R-AXIS conversion diffractometer Absorption correction: multi-scan (CrystalClear-SM Expert; Rigaku, 2013 ▶) T min = 0.831, T max = 1.000 7784 measured reflections 2581 independent reflections 2162 reflections with I > 2σ(I) R int = 0.036

Refinement

R[F 2 > 2σ(F 2)] = 0.030 wR(F 2) = 0.076 S = 1.07 2581 reflections 154 parameters 3 restraints H atoms treated by a mixture of independent and constrained refinement Δρmax = 0.37 e Å−3 Δρmin = −0.24 e Å−3 Data collection: CrystalClear-SM Expert (Rigaku, 2013 ▶); cell refinement: CrystalClear-SM Expert; data reduction: CrystalClear-SM Expert; program(s) used to solve structure: SHELXS97 (Sheldrick, 2008 ▶); program(s) used to refine structure: SHELXL97 (Sheldrick, 2008 ▶); molecular graphics: ORTEP-3 for Windows (Farrugia, 2012 ▶) and DIAMOND (Brandenburg, 2006 ▶); software used to prepare material for publication: publCIF (Westrip, 2010 ▶). Crystal structure: contains datablock(s) general, I. DOI: 10.1107/S1600536814004565/hg5387sup1.cif Structure factors: contains datablock(s) I. DOI: 10.1107/S1600536814004565/hg5387Isup2.hkl Click here for additional data file. Supporting information file. DOI: 10.1107/S1600536814004565/hg5387Isup3.cml CCDC reference: 988939 Additional supporting information: crystallographic information; 3D view; checkCIF report
C11H12ClN2O+·ClF(000) = 536
Mr = 259.13Dx = 1.536 Mg m3
Monoclinic, P21/cMo Kα radiation, λ = 0.71075 Å
Hall symbol: -P 2ybcCell parameters from 14670 reflections
a = 8.2438 (13) Åθ = 3.0–27.5°
b = 16.405 (2) ŵ = 0.56 mm1
c = 8.8561 (14) ÅT = 100 K
β = 110.705 (2)°Prism, colourless
V = 1120.3 (3) Å30.20 × 0.07 × 0.04 mm
Z = 4
Rigaku R-AXIS conversion diffractometer2581 independent reflections
Radiation source: Sealed Tube2162 reflections with I > 2σ(I)
Graphite monochromatorRint = 0.036
Detector resolution: 10.0000 pixels mm-1θmax = 27.5°, θmin = 2.5°
profile data from ω–scansh = −10→9
Absorption correction: multi-scan (CrystalClear-SM Expert; Rigaku, 2013)k = −20→21
Tmin = 0.831, Tmax = 1.000l = −11→11
7784 measured reflections
Refinement on F2Primary atom site location: structure-invariant direct methods
Least-squares matrix: fullSecondary atom site location: difference Fourier map
R[F2 > 2σ(F2)] = 0.030Hydrogen site location: inferred from neighbouring sites
wR(F2) = 0.076H atoms treated by a mixture of independent and constrained refinement
S = 1.07w = 1/[σ2(Fo2) + (0.0353P)2 + 0.170P] where P = (Fo2 + 2Fc2)/3
2581 reflections(Δ/σ)max = 0.001
154 parametersΔρmax = 0.37 e Å3
3 restraintsΔρmin = −0.24 e Å3
Geometry. All s.u.'s (except the s.u. in the dihedral angle between two l.s. planes) are estimated using the full covariance matrix. The cell s.u.'s are taken into account individually in the estimation of s.u.'s in distances, angles and torsion angles; correlations between s.u.'s in cell parameters are only used when they are defined by crystal symmetry. An approximate (isotropic) treatment of cell s.u.'s is used for estimating s.u.'s involving l.s. planes.
Refinement. Refinement of F2 against ALL reflections. The weighted R-factor wR and goodness of fit S are based on F2, conventional R-factors R are based on F, with F set to zero for negative F2. The threshold expression of F2 > 2σ(F2) is used only for calculating R-factors(gt) etc. and is not relevant to the choice of reflections for refinement. R-factors based on F2 are statistically about twice as large as those based on F, and R- factors based on ALL data will be even larger.
xyzUiso*/Ueq
Cl11.02274 (5)0.76756 (2)0.47284 (4)0.01888 (11)
O10.53371 (15)0.30013 (7)0.03702 (13)0.0206 (3)
H1O0.595 (2)0.3400 (9)0.033 (2)0.031*
N10.90024 (17)0.49718 (8)0.69236 (15)0.0153 (3)
H1N0.9879 (17)0.5083 (11)0.7812 (14)0.018*
N20.50113 (17)0.43490 (8)0.27207 (15)0.0153 (3)
H2N0.466 (2)0.4713 (9)0.1961 (17)0.018*
C10.8212 (2)0.42491 (10)0.67877 (18)0.0162 (3)
H10.85710.38860.76810.019*
C20.6904 (2)0.40138 (9)0.54089 (18)0.0152 (3)
H20.63870.34920.53540.018*
C30.63187 (19)0.45441 (9)0.40638 (17)0.0131 (3)
C40.72227 (19)0.53172 (9)0.41947 (18)0.0135 (3)
C50.68800 (19)0.58698 (9)0.28956 (17)0.0145 (3)
H50.59920.57470.18950.017*
C60.7804 (2)0.65795 (9)0.30511 (18)0.0157 (3)
H60.75810.69400.21600.019*
C70.90831 (19)0.67665 (9)0.45450 (18)0.0154 (3)
C80.94774 (19)0.62514 (9)0.58444 (18)0.0153 (3)
H81.03490.63890.68450.018*
C90.85580 (19)0.55131 (9)0.56571 (17)0.0133 (3)
C100.4232 (2)0.35374 (9)0.24153 (19)0.0172 (3)
H10A0.31010.35690.15170.021*
H10B0.40140.33480.33880.021*
C110.5388 (2)0.29206 (10)0.19883 (18)0.0177 (3)
H11A0.65980.29920.27360.021*
H11B0.50140.23630.21440.021*
Cl20.75804 (5)0.45204 (2)0.02211 (4)0.01726 (10)
U11U22U33U12U13U23
Cl10.0192 (2)0.01435 (19)0.02016 (19)−0.00294 (15)0.00339 (15)0.00041 (15)
O10.0244 (6)0.0209 (6)0.0164 (5)−0.0031 (5)0.0071 (5)−0.0019 (5)
N10.0159 (6)0.0175 (7)0.0112 (6)0.0010 (5)0.0030 (5)0.0010 (5)
N20.0163 (6)0.0137 (7)0.0140 (6)0.0000 (5)0.0029 (5)0.0005 (5)
C10.0194 (8)0.0160 (7)0.0146 (7)0.0032 (6)0.0079 (6)0.0021 (6)
C20.0175 (7)0.0133 (7)0.0162 (7)0.0000 (6)0.0077 (6)0.0008 (6)
C30.0130 (7)0.0139 (7)0.0138 (7)0.0031 (6)0.0064 (6)−0.0010 (6)
C40.0133 (7)0.0139 (7)0.0141 (7)0.0014 (6)0.0058 (6)−0.0016 (6)
C50.0143 (7)0.0151 (7)0.0120 (7)0.0021 (6)0.0021 (6)−0.0012 (6)
C60.0160 (7)0.0148 (7)0.0158 (7)0.0029 (6)0.0050 (6)0.0025 (6)
C70.0152 (7)0.0126 (7)0.0196 (7)−0.0003 (6)0.0078 (6)−0.0016 (6)
C80.0133 (7)0.0173 (8)0.0143 (7)0.0011 (6)0.0035 (6)−0.0021 (6)
C90.0144 (7)0.0133 (7)0.0131 (7)0.0035 (6)0.0060 (6)0.0000 (6)
C100.0177 (8)0.0156 (8)0.0177 (7)−0.0043 (6)0.0053 (6)−0.0034 (6)
C110.0209 (8)0.0159 (8)0.0164 (7)−0.0023 (6)0.0066 (6)−0.0002 (6)
Cl20.01711 (19)0.0195 (2)0.01341 (17)0.00029 (15)0.00320 (14)−0.00020 (14)
Cl1—C71.7413 (16)C4—C91.409 (2)
O1—C111.4250 (18)C4—C51.413 (2)
O1—H1O0.838 (9)C5—C61.371 (2)
N1—C11.338 (2)C5—H50.9500
N1—C91.3749 (19)C6—C71.404 (2)
N1—H1N0.879 (9)C6—H60.9500
N2—C31.331 (2)C7—C81.371 (2)
N2—C101.4615 (19)C8—C91.407 (2)
N2—H2N0.869 (9)C8—H80.9500
C1—C21.368 (2)C10—C111.526 (2)
C1—H10.9500C10—H10A0.9900
C2—C31.415 (2)C10—H10B0.9900
C2—H20.9500C11—H11A0.9900
C3—C41.455 (2)C11—H11B0.9900
C11—O1—H1O108.4 (14)C5—C6—H6120.5
C1—N1—C9121.21 (13)C7—C6—H6120.5
C1—N1—H1N119.0 (12)C8—C7—C6122.19 (14)
C9—N1—H1N119.6 (12)C8—C7—Cl1119.32 (12)
C3—N2—C10123.26 (13)C6—C7—Cl1118.48 (12)
C3—N2—H2N117.9 (12)C7—C8—C9118.27 (14)
C10—N2—H2N118.6 (12)C7—C8—H8120.9
N1—C1—C2122.38 (14)C9—C8—H8120.9
N1—C1—H1118.8N1—C9—C8118.87 (13)
C2—C1—H1118.8N1—C9—C4119.93 (14)
C1—C2—C3120.30 (14)C8—C9—C4121.20 (14)
C1—C2—H2119.8N2—C10—C11112.19 (13)
C3—C2—H2119.8N2—C10—H10A109.2
N2—C3—C2122.13 (14)C11—C10—H10A109.2
N2—C3—C4120.72 (13)N2—C10—H10B109.2
C2—C3—C4117.15 (13)C11—C10—H10B109.2
C9—C4—C5117.95 (14)H10A—C10—H10B107.9
C9—C4—C3118.95 (13)O1—C11—C10112.87 (13)
C5—C4—C3123.05 (14)O1—C11—H11A109.0
C6—C5—C4121.27 (14)C10—C11—H11A109.0
C6—C5—H5119.4O1—C11—H11B109.0
C4—C5—H5119.4C10—C11—H11B109.0
C5—C6—C7119.06 (14)H11A—C11—H11B107.8
C9—N1—C1—C2−1.4 (2)C5—C6—C7—Cl1−179.28 (11)
N1—C1—C2—C3−0.9 (2)C6—C7—C8—C90.0 (2)
C10—N2—C3—C2−9.1 (2)Cl1—C7—C8—C9−178.78 (11)
C10—N2—C3—C4170.11 (13)C1—N1—C9—C8−177.54 (14)
C1—C2—C3—N2−177.69 (14)C1—N1—C9—C41.4 (2)
C1—C2—C3—C43.0 (2)C7—C8—C9—N1176.63 (13)
N2—C3—C4—C9177.74 (13)C7—C8—C9—C4−2.3 (2)
C2—C3—C4—C9−3.0 (2)C5—C4—C9—N1−176.31 (13)
N2—C3—C4—C5−5.2 (2)C3—C4—C9—N10.9 (2)
C2—C3—C4—C5174.04 (13)C5—C4—C9—C82.6 (2)
C9—C4—C5—C6−0.6 (2)C3—C4—C9—C8179.74 (13)
C3—C4—C5—C6−177.64 (14)C3—N2—C10—C11−74.61 (18)
C4—C5—C6—C7−1.6 (2)N2—C10—C11—O1−77.07 (16)
C5—C6—C7—C82.0 (2)
D—H···AD—HH···AD···AD—H···A
O1—H1o···Cl20.84 (2)2.30 (2)3.1338 (14)179 (2)
N1—H1n···Cl2i0.88 (1)2.29 (1)3.1602 (15)168 (1)
N2—H2n···Cl2ii0.87 (1)2.49 (2)3.2949 (14)154 (2)
C2—H2···O1iii0.952.603.545 (2)173
Table 1

Hydrogen-bond geometry (Å, °)

D—H⋯A D—HH⋯A DA D—H⋯A
O1—H1o⋯Cl20.84 (2)2.30 (2)3.1338 (14)179 (2)
N1—H1n⋯Cl2i 0.88 (1)2.29 (1)3.1602 (15)168 (1)
N2—H2n⋯Cl2ii 0.87 (1)2.49 (2)3.2949 (14)154 (2)
C2—H2⋯O1iii 0.952.603.545 (2)173

Symmetry codes: (i) ; (ii) ; (iii) .

  9 in total

1.  A short history of SHELX.

Authors:  George M Sheldrick
Journal:  Acta Crystallogr A       Date:  2007-12-21       Impact factor: 2.290

2.  Antiinflammatory and antiarthritic properties of a substituted quinoline carboxylic acid: CL 306,293.

Authors:  A E Sloboda; D Powell; J F Poletto; W C Pickett; J J Gibbons; D H Bell; A L Oronsky; S S Kerwar
Journal:  J Rheumatol       Date:  1991-06       Impact factor: 4.666

3.  Design and synthesis of substituted quinolines as novel and selective melanin concentrating hormone antagonists as anti-obesity agents.

Authors:  Namal C Warshakoon; Justin Sheville; Ritu Tiku Bhatt; Wei Ji; Jose L Mendez-Andino; Kenneth M Meyers; Nick Kim; John A Wos; Chrissy Mitchell; Jennifer L Paris; Beth B Pinney; Ofer Reizes; X Eric Hu
Journal:  Bioorg Med Chem Lett       Date:  2006-07-25       Impact factor: 2.823

4.  Structure-activity relationships in quinoline Reissert derivatives with HIV-1 reverse transcriptase inhibitory activity.

Authors:  M Font; A Monge; I Ruiz; B Heras
Journal:  Drug Des Discov       Date:  1997-04

5.  Quinolone antibacterial agents. Oxolinic acid and related compounds.

Authors:  D Kaminsky; R I Meltzer
Journal:  J Med Chem       Date:  1968-01       Impact factor: 7.446

Review 6.  Antimalarial agents. Chloroquine, hydroxychloroquine, and quinacrine.

Authors:  L Tanenbaum; D L Tuffanelli
Journal:  Arch Dermatol       Date:  1980-05

7.  Antifungal properties of new series of quinoline derivatives.

Authors:  Robert Musiol; Josef Jampilek; Vladimir Buchta; Luis Silva; Halina Niedbala; Barbara Podeszwa; Anna Palka; Katarzyna Majerz-Maniecka; Barbara Oleksyn; Jaroslaw Polanski
Journal:  Bioorg Med Chem       Date:  2006-02-03       Impact factor: 3.641

8.  Direct interaction between a quinoline derivative, MS-209, and multidrug resistance protein (MRP) in human gastric cancer cells.

Authors:  T Nakamura; M Oka; K Aizawa; H Soda; M Fukuda; K Terashi; K Ikeda; Y Mizuta; Y Noguchi; Y Kimura; T Tsuruo; S Kohno
Journal:  Biochem Biophys Res Commun       Date:  1999-02-24       Impact factor: 3.575

9.  Mefloquine-oxazolidine derivatives: a new class of anticancer agents.

Authors:  Felipe A R Rodrigues; Igor da S Bomfim; Bruno C Cavalcanti; Claudia Pessoa; Raoni S B Goncalves; James L Wardell; Solange M S V Wardell; Marcus V N de Souza
Journal:  Chem Biol Drug Des       Date:  2013-10-05       Impact factor: 2.817

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.